Sarah Cannon Leadership and Physician Experts

Dax Kurbegov, MD, serves as Senior Vice President and leads Sarah Cannon, the oncology service line of HCA Healthcare. Dr. Kurbegov oversees all elements of Sarah Cannon’s market operations, ensuring consistency and quality and fostering collaboration across our global network of cancer programs. Across our 90+ Commission on Cancer and Foundation for the Accreditation of Cellular Therapy accredited programs, he ensures that our patients receive personalized care through robust multi-disciplinary conferences, physician-developed clinical pathways and the support of our more than 180 dedicated oncology nurse navigators.

In addition, Dr. Kurbegov is an investigator in the rapidly evolving field of blood-based early cancer detection technologies which promise a convenient way to screen for many cancers at once, including cancers that have had no screening strategies up until now. Sarah Cannon has enrolled more than 30,000 patients in early detection studies and is helping bring forward the very first tests in the commercial setting.

Dr. Kurbegov joined Sarah Cannon in 2017 from Catholic Health Initiatives where he led the national oncology service line. Dr. Kurbegov received his bachelor of science from Stanford University and his medical degree from Baylor College of Medicine. He completed his internship and residency in internal medicine at University of Colorado Health Sciences Center and his medical oncology fellowship from The University of Texas MD Anderson Cancer Center. He has served as a physician advisor for the American Society of Clinical Oncology (ASCO®) CancerLinQ program, and Chair of the ASCO Research Community Forum Steering Group for the 2017-2018 term. He is recognized as a Fellow of the American Society for Clinical Oncology.